Extract of Lepidium meyenii roots for pharmaceutical applications
    21.
    发明授权
    Extract of Lepidium meyenii roots for pharmaceutical applications 有权
    用于制药应用的梅毒根提取物

    公开(公告)号:US06267995B1

    公开(公告)日:2001-07-31

    申请号:US09261806

    申请日:1999-03-03

    IPC分类号: A61K3578

    CPC分类号: A61K36/31

    摘要: An isolated composition obtained by extracting Lepidium meyenii roots is provided. The composition is substantially free of cellulose and comprises between about 5% and about 9% of benzyl isothiocyanate, between about 1% and about 3% of Lepidium sterol component, between about 20% and about 30% of Lepidium fatty acid component, and about 10% or more of macamide component. The composition is prepared by a process which comprises contacting Lepidium meyenii roots with a first aqueous solvent of about 90% vol-% or more water, then separating the residual Lepidium meyenii root material from the first contacted aqueous solvent, then contacting the residual Lepidium meyenii root material with a second aqueous solvent which comprises a mixture of an alcohol and water having about 90 vol-% alcohol or more to form a liquor, and then finally concentrating the liquor to obtain the composition. The composition can be used for treating cancer and sexual dysfunction.

    摘要翻译: 提供了通过提取梅毒根获得的分离组合物。 所述组合物基本上不含纤维素,并且包含约5%至约9%的异硫氰酸苄酯,约1%至约3%的Lepidium sterol组分,约20%至约30%的Lepidium脂肪酸组分和约 10%以上的macamide成分。 组合物通过以下方法制备,该方法包括使梅毒根与约90%体积%或更多的水的第一含水溶剂接触,然后从残留的第一次接触的水性溶剂中分离剩余的梅毒根部物质,然后将剩余的梅毒 根部材料与第二含水溶剂组成,其包含具有约90体积%醇或更多醇的醇和水的混合物以形成液体,然后最终将液体浓缩以获得组合物。 该组合物可用于治疗癌症和性功能障碍。